Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies

Mycoses

Volumn 56, Issue 4, 2013, Pages 442-448

  Jha, Ajaya K ^a   Bansal, Deepak ^a   Chakrabarti, Arunaloke ^a   Shivaprakash, M R ^a   Trehan, Amita ^a   Marwaha, Ram K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acute lymphoblastic leukaemia; Acute myeloid leukaemia; CT scan; Febrile neutropenia; Functional endoscopic sinus surgery; Immunocompromised

Indexed keywords

AMIKACIN; AMPHOTERICIN; GALACTOMANNAN; ITRACONAZOLE; MEROPENEM; SULPERAZON; VANCOMYCIN;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; ASPERGILLUS; AUTOPSY; BLOOD CULTURE; BLOOD SAMPLING; BURKITT LYMPHOMA; CHILD; CHILDHOOD DISEASE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; INVASIVE ASPERGILLOSIS; LUNG LAVAGE; LUNG NODULE; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TRANSBRONCHIAL BIOPSY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FUNGEMIA; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SERUM;

ASPERGILLUS;

EID: 84879240055     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12048     Document Type: Article

References (28)

1. Kontoyiannis DP, Bodey GP. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis 2002; 21: 161-72.
2. Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med 2012; 125(Suppl. 1): S14-24.
3. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609-22.
4. Zaoutis TE, Heydon K, Chu JH et al. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000. Pediatrics 2006; 117: e711-6.
5. Latgé JP, Kobayashi H, Debeaupuis JP et al. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun 1994; 62: 5424-33.
6. Marr KA, Balajee SA, McLaughlin L et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190: 641-9.
7. Leeflang MM, Debets-Ossenkopp YJ, Visser CE et al. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev 2008: CD007394.
8. Viscoli C, Machetti M, Cappellano P et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004; 38: 913-6.
9. Steinbach WJ, Addison RM, McLaughlin L et al. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 2007; 26: 558-64.
10. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
11. Vaideeswar P, Prasad S, Deshpande JR, Pandit SP. Invasive pulmonary aspergillosis: a study of 39 cases at autopsy. J Postgrad Med 2004; 50: 21-6.
12. Chakrabarti A, Chatterjee SS, Das A, Shivaprakash MR. Invasive aspergillosis in developing countries. Med Mycol 2011; 49(Suppl. 1): S35-47.
13. Castagnola E, Furfaro E, Caviglia I et al. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. Clin Microbiol Infect 2010; 16: 1197-203.
14. Subira M, Martino R, Rovira M et al. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 2003; 82: 80-2.
15. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
16. Tsitsikas DA, Morin A, Araf S et al. Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis. Med Mycol 2012; 50: 538-42.
17. Tanriover MD, Ascioglu S, Altun B, Uzun O. Galactomannan on the stage: prospective evaluation of the applicability in routine practice and surveillance. Mycoses 2010; 53: 16-25.
18. Sulahian A, Boutboul F, Ribaud P et al. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study. Cancer 2001; 91: 311-8.
19. Suankratay C, Kanitcharaskul P, Arunyingmongkol K. Galactomannan Antigenemia for the diagnosis of invasive aspergillosis in neutropenic patients with hematological disorders. J Med Assoc Thai 2006; 89: 1851-8.
20. Herbrecht R, Letscher-Bru V, Oprea C et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898-906.
21. Oz Y, Kiraz N. Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods. Expert Rev Anti Infect Ther 2011; 9: 289-98.
22. Hayden R, Pounds S, Knapp K et al. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr Infect Dis J 2008; 27: 815-9.
23. Tortorano AM, Esposto MC, Prigitano A et al. Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol 2012; 50: 1051-3.
24. Ghosh I, Raina V, Kumar L, Sharma A, Bakhshi S, Iqbal S. Serum galactomannan (GM) assay for invasive aspergillosis (IA) in acute leukemia (AL) and hematopoietic stem cell transplantation (HSCT). J Clin Oncol 2011; 29(Suppl.; abstr 6538): http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=102&abstractID=73905 [accessed on 1 November 2012].
25. Caillot D, Couaillier JF, Bernard A et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253-9.
26. Park SY, Lim C, Lee SO et al. Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value. J Infect 2011; 63: 447-56.
27. Lehrnbecher T, Phillips R, Alexander S et al. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol 2012; 30: 4427-38.
28. Woods G, Miceli MH, Grazziutti ML et al. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Cancer 2007; 110: 830-4.